News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Sysmex Corporation Starts Joint Research with National Cancer Center Hospital to Verify Clinical Usefulness of Technology for Detecting Circulating Tumor Cells



3/22/2010 8:34:01 AM

Kobe, Mar 16, 2010 (JCN Newswire) - Sysmex Corporation (TSE: 6869) has started research jointly with the National Cancer Center Hospital to verify clinical usefulness of a technology developed by Sysmex for detecting living tumor cells suspended in blood (CTC detection technology).

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES